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Introduction
replication, and further showed that this was likely mediated via interactions of NS5A 145 with a defined subset of cellular factors (23, 37) . A caveat to these studies was the 146 necessary dependence on interpretation of data based on the analysis of the 147 phenotype of S225 mutants (S225A phosphoablatant or S225D phosphomimetic). To 148 address this we raised a rabbit polyclonal antiserum specific for the S225 149 phosphorylated form of NS5A using an appropriate phosphopeptide as immunogen 150 (CARGSPPpSEASSS). The resulting anti-pS225 antiserum was validated by 151 immunoblotting ( Fig 1B) and reassuringly detected a single NS5A band in a lysate 152 from Huh7 cells infected with wildtype HCV (mJFH-1). Consistent with the previous 153 observation that the S225A phosphoablatant mutant resulted in a loss of p58 (37), the 154 pS225 reactive species corresponded with this form of NS5A, illustrated by the merged 155 image of pS225 (green) and total NS5A (red) signals. As expected, the pS225 156 antiserum exhibited no reactivity against the S225A mutant. perinuclear concentration of LD ( Fig S2A) . This may be due to the role of GSK3β in 216 lipid metabolism (42).
217
Evidence for a role of S225 phosphorylation in initiating hierarchical 218 phosphorylation in LCSI 219 A number of lines of evidence points to a hierarchical, or sequential, phosphorylation 220 cascade across LCSI. These include the conservation and spacing of the serine 221 residues, and mass spectrometric evidence for multiply-phosphorylated species 222 corresponding to LCSI (31, 38, 43) . Additionally the group of Yu (33) recently 223 generated pS235 and pS238-specific antisera and demonstrated that pS238 was 224 dependent on pS235, but not vice-versa, suggesting that S235 was the primary 225 phosphorylation site leading to a hierarchical phosphorylation of other serines within 226 LCSI. However, they did not address the potential role of S225phosphorylation, and 227 we hypothesised that this might precede phosphorylation of S235 and initiate the 228 hierarchical phosphorylation cascade. 229 To provide evidence for this hypothesis we used western blot analysis to examine the 230 presence of pS225 reactivity in lysates of cells infected with mJFH-1 phosphoablatant 231 mutants: S222A, S225A, S228A, S230A and S238A. We were unable to interrogate 232 the remaining phosphoablatant mutants as they were replication-inactive. As shown 233 in Fig 5A, the only mutant which affected pS225 reactivity was S225A itself, indicating 234 that this phosphorylation event was independent of other phosphorylated serines in 235 LCSI.
236
In a previous study (43) we generated an antibody specific to pS222. Although this 237 reagent was in scarce supply, we had sufficient to interrogate the same samples for 238 the presence of pS222. As expected, S222A exhibited significantly reduced levels of pS222 within the p58 species ( Fig 5B) , however this mutant retained wildtype level of 240 reactivity for the p56 species. We believe this reflects reactivity against the non-241 phosphorylated sequence and is due to the fact that this serum was not affinity purified 242 using the phospho-peptide (as had the pS225 antiserum). Importantly, the only other 243 phosphoablatant mutant that blocked pS222 was S225A. These observations are 244 consistent with the suggestion that S225 phosphorylation is the 'priming' event that 245 leads to a bi-directional hierarchical cascade of phosphorylation events. 246 We also used confocal microscopy with Airyscan to analyse the distribution of both 247 total NS5A and pS225-NS5A in cells infected with the various phosphoablatant 248 mutants. As shown in Fig 6, all mutants displayed a broad cytoplasmic distribution of 249 total NS5A that was similar to wildtype, with the exception of S225A which exhibited a 250 more compact perinuclear distribution, as documented previously (23). However, as 251 observed in Fig 1, we noted again that in all cases there was a subset of total NS5A 252 reactivity that did not stain for pS225, and this led us to investigate this observation in 253 more detail. We thus undertook a temporal analysis of the distribution of total NS5A, cytoplasmic punctae in comparison to wildtype or the phosphomimetic S225D NS5A 266 (23). In our laboratory at present dSTORM analysis is restricted to a single-colour, 267 however, to assess the distribution of pS225 in comparison to total NS5A would 268 require multi-colour capability. We therefore decided to utilise the novel super- We first confirmed the capability of ExM to improve the resolution using our facilities 280 (Zeiss LSM880). To do this we analysed vimentin intermediate filaments in Huh7 281 cells by immunofluorescence, and then compared the microscope images pre-and 282 post-expansion (Fig 8) . Whereas the pre-expansion image showed individual 283 vimentin filaments with blurred edges (Fig 8A) , the ExM image allowed clear 284 distinction of the substructures within the filaments ( Fig 8B) . Quantification of the 285 intensity profiles revealed more precise resolution of this sub-filamentous structure 286 ( Fig 8C) . We therefore applied this technique to interrogate pS225-NS5A and total 287 NS5A distribution in Huh7 cells electroporated with mJFH-1 RNA at different times.
As observed using Airyscan, ExM analysis revealed a diffuse distribution of NS5A 289 throughout the cytoplasm ( Fig 9A) with significant co-localisation between NS5A and 290 pS225 (merge panel). Over time, the diffuse distribution resolved into a more 291 clustered appearance with an overall increase in the size of NS5A-positive structures.
292
Quantification confirmed this as the peak area of these structures increased from 0.09-293 0.12 μm 2 at 24 h.p.e., to 0.15-0.18 μm 2 at 72 h.p.e. (Fig 8B) .
294
For comparison, cells harbouring wildtype or S225A mutant SGR-Neo-JFH1 were also 295 analysed by ExM. As expected wildtype NS5A was distributed throughout the 296 cytoplasm ( Fig 10A) , whereas S225A was restricted to the perinuclear region ( Fig   297   10B ). Interestingly, the proportion of NS5A punctae that were pS225 positive was 298 higher than for virus-infected cells ( Fig 10B green bars) . Wildtype NS5A positive 299 punctae were on average smaller (peak 0.09-0.12 μm 2 ) than those in infected cells, 300 however the S225A mutant exhibited significantly condensed and larger punctae 301 (peak 0.18-0.21 μm 2 ). It has been reported that treatment of HCV-infected cells with 302 the NS5A inhibitor DCV resulted in a perinuclear accumulation of NS5A (13), 303 reminiscent of that observed for the S225A mutant. We therefore treated wildtype 304 SGR harbouring cells with DCV and analysed the distribution of total NS5A and 305 pS225-NS5A by ExM ( Fig 10C) . Significant clustering of NS5A punctae was observed 306 and size analysis revealed a bimodal distribution with two populations of punctae 307 exhibiting small (peak 0.06-0.09 μm 2 ) and large (peak 0.21-0.24 μm 2 ) areas. The large 308 population corresponded to those punctae observed in S225A mutant SGR harbouring 309 cells.
310
Next, to fully exploit the improved resolution afforded by ExM, we undertook a 3D- as seen for S225A with pS225 distributed across these clusters often at the edges.
329
To quantify this we measured intensity profiles across the clusters (Fig 12) . In both 
Discussion

338
Despite extensive study over many years, the functions of NS5A remain to be 339 unambiguously defined, an issue brought into sharp focus by the advent of DAAs that 340 are predicted to target NS5A. These compounds are highly effective at inhibiting HCV 341 replication, both in vitro and in patients, yet virtually nothing is known about their mode 342 of action, or indeed which of the many NS5A functions they inhibit. In this regard, a 343 growing body of evidence points to phosphorylation as a key regulator of NS5A 344 function, however, it is only recently that the phosphorylation sites and kinases that 345 phosphorylate them have begun to be identified. Our studies have focused on S225 346 in the serine-rich LCSI between DI and DII, for reasons outlined in the introduction.
347
Here we describe the use of an unique reagent -an antiserum specific for pS225 that 348 has allowed us for the first time to directly interrogate the role of S225-phosphorylated 349 NS5A. 350 Firstly, we showed that pS225 was exclusively present on the p58 NS5A species and 351 identified CKIα and PLK1 as candidate S225 kinases. Pharmacological inhibition of 352 either kinase resulted in a loss of pS225 and p58, but also resulted in a reduction in 353 the overall levels of NS5A. This is likely due to an effect on genome replication and is 354 consistent with the 10-fold reduction in replication seen previously with the S225A 355 phosphoablatant mutant (37). We also observed that inhibition of these kinases 356 resulted in a loss of co-localisation of NS5A with LDs, suggesting that this association 357 is required for efficient genome replication, in addition to its requirement for virus 358 assembly (19, 47).
359
Previously we had observed that the S225A phosphoablatant mutant had an extensive 360 phenotype (23, 37) and we considered this a disproportionate effect of a single serine-alanine substitution in a highly serine-rich region ( Fig 1A) . This prompted us to respective to each other. 374 We then combined the pS225 antiserum with two super-resolution microscopy 375 approaches -Airyscan and ExM -techniques which overcome the light diffraction limit 376 of conventional microscopy, to interrogate the subcellular distribution of pS225-NS5A 377 in comparison to the total pool of NS5A. This revealed that pS225-NS5A was only a 378 subset of the total, consistent with the presence of both p56 (lacking pS225) and p58 379 (pS225-positive) species by western blot (Fig 1B) . However, surprisingly we observed 380 that pS225 was not uniformly distributed across the total NS5A (Fig 7) . Three-381 dimensional reconstruction of NS5A clusters imaged by ExM revealed that pS225 foci 382 were surface exposed and in many cases were close to holes that extended through 383 the cluster (Fig 11) . These holes are likely to represent LDs which cannot be directly either the S225A phosphoablatant mutation, or DCV treatment of wildtype (Fig 11) . 398 The compact and smooth architecture of the wildtype NS5A cluster with holes (LDs) 399 extending through the structure was replaced with an expanded and irregular structure 400 with less distinct holes. The similarities suggest that S225 phosphorylation and DCV 401 might regulate some common function(s) of NS5A, possibly involved in protein-protein 402 and/or protein-lipid interactions. Again, this is consistent with previous studies showing 403 that DCV treatment disrupted the structure, distribution and formation of membrane-404 associated replication complexes (49, 50) . As a note of caution, it should be noted 405 that these previous studies were performed with NS3-5B expression constructs, rather 406 than in the context of HCV infection.
407
In conclusion, our study provides more evidence supporting the critical role of 408 phosphorylation in regulating the function of NS5A. In particular we propose that S225 409 phosphorylation is the primary site within LCSI that primes subsequent to the cluster that is subject to 3D-reconstruction in Fig 11. (B) The size of individual 573 NS5A and pS225-NS5A particles was determined and plotted as a frequency 
